For women in perimenopause or menopause, individualized care is especially important
GLP-1 medications such as semaglutide and tirzepatide are injected under the skin (subcutaneous), not into muscle
GLP1 is a gut-derived polypeptide released from the intestinal L cells, capable of stimulating glucose-dependent insulin secretion and inhibiting food intake by acting on the pancreas and brain, respectively
"Many of the patients who received vials of compounded semaglutide lacked experience with self-injections, according to the adverse event reports," the FDA said in a July 26 statement
Start provider review What You'll Learn MK-677 raises GH and IGF-1 in human trials, but it has no FDA-approved indication and was discontinued before receiving one
Because retatrutide is not yet licensed in the UK, anyone currently taking it should be doing so within a clinical trial or specialist research programme, with a named clinician or research team overseeing their care